Flávio Teles

Flávio Teles

Auto-generated profile, based on publicly available information

Flávio Teles

Renal Division, Faculty of Medicine, Federal University of Alagoas, Maceio 57200-000, AL, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2019 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MSMarcelo Augusto Duarte Silveira
Marcelo Augusto Duarte Silveira
FTFlávio Teles
Flávio Teles
Andresa BerrettaAndresa Berretta
Andresa Berretta
TSTalita R. Sanches
Talita R. Sanches
CRCamila Eleutério Rodrigues
Camila Eleutério Rodrigues
LALúcia Conceição Andrade
Lúcia Conceição Andrade
Chronic kidney disease (CKD) is a public health problem worldwide, and proteinuria is a well-established marker of disease progression in CKD patients. Propolis, a natural resin produced by bees from plant materials, has anti-inflammatory, immunomodulatory, and anti-oxidant properties, as well as having been shown to have an antiproteinuric effect in experimental CKD. The aim of this study was to evaluate the impact of Brazilian green propolis extract on proteinuria reduction and the changes in the estimated glomerular filtration rate (eGFR). This was a randomized, double-blind, placebo-controlled study including patients with CKD caused by diabetes or of another etiology, 18–90 years of age, with an eGFR of 25–70 ml/min per 1.73 m2 and proteinuria (urinary protein excretion > 300 mg/day) or micro- or macro-albuminuria (urinary albumin-to-creatinine ratio > 30 mg/g or > 300 mg/g, respectively). We screened 148 patients and selected 32, randomly assigning them to receive 12 months of Brazilian green propolis extract at a dose of 500 mg/day (n = 18) or 12 months of a placebo (n = 14). At the end of treatment, proteinuria was significantly lower in the propolis group than in the placebo group—695 mg/24 h (95% CI, 483 to 999) vs. 1403 mg/24 h (95% CI, 1031 to 1909); P = 0.004—independent of variations in eGFR and blood pressure, which did not differ between the groups during follow-up. Urinary monocyte chemoattractant protein-1 was also significantly lower in the propolis group than in the placebo group—58 pg/mg creatinine (95% CI, 36 to 95) vs. 98 pg/mg creatinine (95% CI, 62 to 155); P = 0.038. Brazilian green propolis extract was found to be safe and well tolerated, as well as to reduce proteinuria significantly in patients with diabetic and non-diabetic CKD. Trial Registration. ( ClinicalTrials.gov number NCT02766036. Registered: May 9, 2016).

1 March 2014 in Clinics
Verified
Journal Article
Open access
FTFlavio Teles
Flavio Teles
VAVega Figueiredo Dourado de Azevedo
Vega Figueiredo Dourado de Azevedo
CMClaudio Torres de Miranda
Claudio Torres de Miranda
MMMilma Pires de Melo Miranda
Milma Pires de Melo Miranda
MTMaria Do Carmo Teixeira
Maria Do Carmo Teixeira
RERosilene M. Elias
Rosilene M. Elias
Depression is the most important neuropsychiatric complication in chronic kidney disease because it reduces quality of life and increases mortality. Evidence demonstrating the association between dialysis shift and depression is lacking; thus, obtaining such evidence was the main objective of this study. This cross-sectional study included patients attending a hemodialysis program. Depression was diagnosed using Beck's Depression Inventory. Excessive daytime sleepiness was evaluated using the Epworth Sleepiness Scale. A total of 96 patients were enrolled (55 males, age 48±14 years). Depression and excessive daytime sleepiness were observed in 42.7% and 49% of the patients, respectively. When comparing variables among the three dialysis shifts, there were no differences in age, dialysis vintage, employment status, excessive daytime sleepiness, hemoglobin, phosphorus levels, or albumin levels. Patients in the morning shift were more likely to live in rural areas (p<0.0001), although patients in rural areas did not have a higher prevalence of depression (p = 0.30). Patients with depression were more likely to be dialyzed during the morning shift (p = 0.008). Independent risk factors for depression were age (p<0.03), lower levels of hemoglobin (p<0.01) and phosphorus (p<0.01), and dialysis during the morning shift (p = 0.0009). The hospitalization risk of depressive patients was 4.5 times higher than that of nondepressive patients (p<0.008). These data suggest that depression is associated with dialysis shift, higher levels of phosphorus, and lower levels of hemoglobin. The results highlight the need for randomized trials to determine whether this association occurs by chance or whether circadian rhythm disorders may play a role.

1 January 2021 in Renal Failure
Verified
Journal Article
Open access
RBRodrigo Bezerra
Rodrigo Bezerra
FTFlávio Teles
Flávio Teles
PMPolyana Bezerra Mendonca
Polyana Bezerra Mendonca
TDTedla Damte
Tedla Damte
ALAndrew Likaka
Andrew Likaka
JFJosé Luiz de Lima Filho
José Luiz de Lima Filho
Early reports indicate that AKI is common during COVID-19 infection. Different mortality rates of AKI due to SARS-CoV-2 have been reported, based on the degree of organic dysfunction and varying fr...

13 January 2023 in Renal Failure
Verified
Journal Article
Open access
FTFlávio Teles
Flávio Teles
JCJorge Artur Peçanha de Miranda Coelho Coelho
Jorge Artur Peçanha de Miranda Coelho Coelho
RARosivânia Maria Albino
Rosivânia Maria Albino
FPFernanda Cristina Verçosa Pacheco
Fernanda Cristina Verçosa Pacheco
EOEvilly Rodrigues de Oliveira
Evilly Rodrigues de Oliveira
RBRodrigo Bezerra
Rodrigo Bezerra
Thiazide diuretics are first-line drugs for the treatment of hypertension, but hypertension treatment guidelines have systematically discouraged their use in patients with advanced chronic kidney d...

1 March 2019 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
FTFlávio Teles
Flávio Teles
RSRenata Oliveira Santos
Renata Oliveira Santos
HLHelder Marx Almeida de Moura Lima
Helder Marx Almeida de Moura Lima
RCRodrigo Peixoto Campos
Rodrigo Peixoto Campos
ETEline Calumby Teixeira
Eline Calumby Teixeira
JCJorge Artur Peçanha de Miranda Coelho Coelho
Jorge Artur Peçanha de Miranda Coelho Coelho
Introduction: Aging is a global phenomenon. Recent forecasts indicate that Brazil will be the sixth country in population of elderly individuals in 2020. The incidence of acute kidney injury (AKI) among the elderly varies, but studies have indicated that older individuals are more prone to developing AKI and have higher mortality rates than the general population with renal disease. The impact of dialysis in elderly patients with AKI - and critically ill individuals with multiple dysfunctions - has been discussed for years. Evidence indicates that for this group of patients dialysis does not positively impact survival and, in some situations, it might even accelerate death. This study investigated a population of elderly individuals with AKI seen in intensive care units to assess, through Propensity Score Matching, the impact dialysis has had for them. Methods: Data from the charts of patients aged 60 years or older seen at the intensive care unit of a general hospital between January 2012 and December 2014 and diagnosed with AKI were collected. Results: The study included 329 patients with a mean age of 75.4 ± 9.3 years. Ischemic AKI was the most prevalent disease (54.7%) and 28.9% of the patients needed dialysis. No difference was seen in the death rates of dialysis and non-dialysis patients aged 70+ years. Conclusions: The data suggested that dialysis did not seem to impact the death rates of critically ill patients with AKI aged 70+ years.

18 July 2017 in Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
FTF. Teles
F. Teles
WRW. G. Rodrigues
W. G. Rodrigues
MAM. G. T. C. Alves
M. G. T. C. Alves
CAC. F. T. Albuquerque
C. F. T. Albuquerque
SBS. M. O. Bastos
S. M. O. Bastos
FSF. J. L. Silva
F. J. L. Silva
Sepsis is a prevalent disease worldwide and still exhibits high rates of mortality. In the last years, many interventions aiming a positive impact on sepsis evolution have been studied. One of the main is the use of managed care protocols (sepsis bundles), which consist in systematization of diagnosis and treatment, such as standardization of antibiotics, collection of specific tests (cultures, lactate), and fluid replacement. Some studies have shown a reduction in hospital costs and lower mortality with the use of these tools. In the present study, we evaluated the impact of a sepsis bundle in wards of a tertiary hospital. One hundred sixty-seven patients were retrospectively studied. The intervention was called “3-h bundle” and consisted of collecting lactate and cultures, start broad-spectrum antibiotics in the first hour of sepsis diagnosis, and volume replacement with crystalloid if hypotension or lactate ≥2 mmol/L. The overall mortality was 31.1%. Individuals who received the 3-h bundle showed a 44% lower mortality in comparison with who did not (25.6 vs. 45.7%; p = 0.01). Furthermore, the use of the sepsis bundle was independently correlated with lower mortality (OR = 0.175; CI = 0.04–0.64; p = 0.009). Therefore, a lower need for ICU admission and shorter length of stay in these units were observed in patients who received the intervention. The use of a sepsis protocol with systematic care in wards was associated with lower mortality, less need for ICU admission and shorter stay on these units.